Rapid triaging, treatment response assessment and outcome prediction in COVID-19 patients

在医疗保健领域，及时和个性化的干预措施对当前和未来各种疾病治疗的最终有效性至关重要。对于COVID-19也是如此，早期发现将显著改善患者预后。AINOSTICS的技术代表了一项突破，将提供一个自动化、可扩展和个性化的医疗保健平台，利用多模态临床成像和非成像数据，协助临床诊断和管理COVID-19患者;对患者的治疗有用，重要的是，我们希望AINOSTICS的软件成为临床实践和药物开发的常规部分，因为我们的智能分析结果将为临床医生，对于严重的全球性疾病，AINOSTICS的技术有可能在患者评估期间节省时间，加快临床路径，提高护理质量和改善患者结局，此外还为疾病修饰疗法的发展做出重要贡献。

In healthcare, timely and personalised interventions have a crucial role in the ultimate effectiveness of both current and future treatments for a wide range of diseases. This is also true for COVID-19, where early detection would result in a significantly improved patient prognosis. AINOSTICS' technology represents a breakthrough that would provide an automated, extensible, and personalised healthcare platform for assisting the clinical diagnosis and management of patients suffering from COVID-19, using multi-modal clinical imaging and non-imaging data; useful for both the treatment of patients, and importantly, in the development of novel therapeutics.We intend for AINOSTICS' software to become a routine part of clinical practice and drug development as the results of our intelligent analysis will provide clinicians, researchers, and imaging centres a convenient and cost-effective means to get reliable, quantitative and objective diagnostic data.For serious global diseases, AINOSTICS' technology has the potential to save time during patient assessments, accelerate clinical pathways, standardise the quality of care and improve patient outcomes, in addition to making important contributions to the development of disease modifying therapeutics.